Advertisement
Organisation › Details
ZGene A/S
ZGene A/S is a privately held Danish biotechnology company founded in 2001. ZGene A/S holds the rights for a prodrug activation system, called ZASTM, which drastically enhances the effect of current anticancer and antiviral drugs and reduces their toxicity. ZGene collaborates with leading academic and industrial partners in the field of cancer therapy and innovative gene delivery. ZGene is based in the Medicon Valley Region in Denmark.The company was founded by private investors, NsGene A/S, and NeuroSearch A/S. Dansk Innovations investering I/S and Symbion Capital I has since entered the company through capital investments. *
Start | 2001-01-01 established (approx) | |
Region | Denmark_oo | |
Country | Denmark | |
City | n. a. | |
Tel | +45-4525-9220 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: | ||
Record changed: 2024-02-12 |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top